Drugs / VV-GMCSF-Lact
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05376527 | May 2022 → Feb 2025 | virus associated tumor | "Oncostar" LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VV-GMCSF-Lact | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05376527 ↗ |
| Route | Other | “Intratumoral injections” NCT05376527 ↗ |